Q1 2024 · 13F-HR
Alerce Investment Management, L.P.holdings as filed
Filed 2024-05-09 · accession 0000895345-24-000166
$95.1M
Reported value
5
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03589W102 | ANNX | ANNEXON INC | $53.1M | 55.8% | 7,406,024 | Common | SOLE |
| 00972D105 | AKBA | AKEBIA THERAPEUTICS INC | $24.2M | 25.4% | 13,205,119 | Common | SOLE |
| 03044L105 | — | AMERICAN WELL CORP | $8.5M | 8.93% | 10,475,717 | Common | SOLE |
| 00887A204 | RNTX | AILERON THERAPEUTICS INC | $5.5M | 5.79% | 830,466 | Common | SOLE |
| 00032Q104 | WHWK | AADI BIOSCIENCE INC | $3.8M | 4.01% | 1,630,830 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.